Report in today's Australian Life Scientist
http://www.biotechnews.com.au/index.php?id=1494073475&eid=-2
============================================
Biotech briefs
Imugene to commercialise, Viralytics to present, Solbec eyes expansion
Dylan Bushell-Embling 09/09/2008 15:07:00
Animal health company Imugene [ASX: IMU] has reported small losses this financial year, but has made progress towards commercialising two products.
The company recorded a net loss of $1.9 million, and a net cash outflow of $1.2 million, and the company said it has developed two animal vaccines with healthy earning potential.
The first, a vaccine for porcine reproductive and respiratory syndrome (PPRS), has been tested and the company is currently seeking licensees. Imugene will soon undergo final trials of the second, a vaccine for coccidiosis in chickens, which will be tested to determine the optimal dosage.
prrs vaccine proves highly effective, page-5
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.3¢ |
Change
-0.001(1.85%) |
Mkt cap ! $389.5M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.6¢ | 5.3¢ | $615.0K | 11.39M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 25 | 2977440 | 5.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.4¢ | 283236 | 4 |
View Market Depth
| Last trade - 16.10pm 30/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |